Sight Sciences announced the launch of its “Don’t Wait for Too Late” educational campaign designed to raise awareness among the optometric community of MIGS as an earlier surgical intervention for glaucoma.

“As optometrists, we are really in a unique position when it comes to glaucoma management, particularly when it comes to earlier surgical intervention, because we are often the gatekeepers for our patients,” says Justin Schweitzer, OD, FAAO, of Vance Thompson Vision.

According to Dr. Schweitzer, the campaign will educate the optometric community “on the safety, efficacy and benefits of MIGS as an earlier surgical treatment option, an important step to expanding patient access and ensuring appropriate and timely referrals to our ophthalmology partners.”

Sight Science’s MIGS (OMNI Surgical System) received FDA clearance for use not only in combination with cataract surgery, but also as a standalone procedure to lower IOP in adult patients who have primary open-angle glaucoma. OM